Evidence map›Paper›PMID 31270049›Full record

ArticleNan fang yi ke da xue xue bao = Journal of Southern Medical University2019

[A non-coated enzyme-linked immunosorbent assay for screening zika virus envelope protein].

Hongmiao Liu, Weifeng Zhou, Hui Liao, Zhengyang Hu, Min Zou, Shuwen Liu

Abstract read
In one paragraph

Article in Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 77% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Hongmiao LiuSchool of Pharmaceutical Sciences, Guangdong Provincial Key Lab of Drug Screening, Guangzhou Key Lab of Drug Research for Emerging Virus Prevention and Treatment, Guangzhou 510515, China.
Weifeng ZhouSchool of Pharmaceutical Sciences, Guangdong Provincial Key Lab of Drug Screening, Guangzhou Key Lab of Drug Research for Emerging Virus Prevention and Treatment, Guangzhou 510515, China.
Hui LiaoSchool of Pharmaceutical Sciences, Guangdong Provincial Key Lab of Drug Screening, Guangzhou Key Lab of Drug Research for Emerging Virus Prevention and Treatment, Guangzhou 510515, China.
Zhengyang HuSchool of Pharmaceutical Sciences, Guangdong Provincial Key Lab of Drug Screening, Guangzhou Key Lab of Drug Research for Emerging Virus Prevention and Treatment, Guangzhou 510515, China.
Min ZouSchool of Pharmaceutical Sciences, Guangdong Provincial Key Lab of Drug Screening, Guangzhou Key Lab of Drug Research for Emerging Virus Prevention and Treatment, Guangzhou 510515, China.
Shuwen LiuSchool of Pharmaceutical Sciences, Guangdong Provincial Key Lab of Drug Screening, Guangzhou Key Lab of Drug Research for Emerging Virus Prevention and Treatment, Guangzhou 510515, China.
Guangdong Pharmaceutical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo establish a non-coated enzyme-linked immunosorbent assay (ELISA) based on zika virus envelope (E) protein for detecting the expression of E protein in infected cells.

methodsAdherent Vero-143 cells infected with zika virus in a 96-well plate were fixed, and the antibodies against zika virus E protein were added at an optimized concentration to establish the non-coated ELISA method for E protein. The antiviral activities of lignans compound C1 was evaluated using this method. The accuracy of this non-coated ELISA was verified by RT-PCR, and the cross reaction with dengue virus was assessed.

resultsAfter optimization, the background absorbance at 450 nm of uninfected cells was reduced to about 0.20. The antiviral activities of lignans compound C1 detected by this method were basically consistent with the results of RT-PCR. No cross reaction with dengue virus was found in this assay.

conclusionsA non- coated ELISA method based on zika virus E protein was established, which can be used for screening antiviral agents against zika virus.

Indexed as

Zika VirusZika Virus InfectionAntibodies, ViralEnzyme-Linked Immunosorbent AssayHumansImmunoglobulin GImmunoglobulin MViral Envelope ProteinsAntibodies, ViralImmunoglobulin GImmunoglobulin MViral Envelope Proteinsantiviralscross reactionenvelope proteinenzyme-linked immunosorbent assayzika virus

Identifiers

PMID31270049
PMCPMC6743923
OpenAlexW2993034586

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.